Hypercholesterolemia Impairs Immunity to Tuberculosis
暂无分享,去创建一个
[1] D. Greiner,et al. Tuberculosis susceptibility of diabetic mice. , 2007, American journal of respiratory cell and molecular biology.
[2] L. Rohrer,et al. Dyslipidemia inhibits Toll-like receptor–induced activation of CD8α-negative dendritic cells and protective Th1 type immunity , 2007, The Journal of experimental medicine.
[3] L. Dijkhuizen,et al. A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages , 2007, Proceedings of the National Academy of Sciences.
[4] H. S. Brown,et al. Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas. , 2006, The American journal of tropical medicine and hygiene.
[5] S. Behar,et al. In Vivo Depletion of CD11c+ Cells Delays the CD4+ T Cell Response to Mycobacterium tuberculosis and Exacerbates the Outcome of Infection1 , 2005, The Journal of Immunology.
[6] M. H. Vargas,et al. A cholesterol-rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis. , 2005, Chest.
[7] D. Grainger,et al. Apolipoprotein E Modulates Clearance of Apoptotic Bodies In Vitro and In Vivo, Resulting in a Systemic Proinflammatory State in Apolipoprotein E-Deficient Mice1 , 2004, The Journal of Immunology.
[8] E. Fisher,et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. , 2004, Immunity.
[9] Desmond E. Williams,et al. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. , 2004, American journal of epidemiology.
[10] M. Netea,et al. Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis. , 2004, Medical mycology.
[11] K. Moore,et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways , 2004, Nature Medicine.
[12] B. Strandvik,et al. Severe Hypercholesterolaemia Leads to Strong Th2 Responses to an Exogenous Antigen , 2004, Scandinavian journal of immunology.
[13] Gladys B. Mutangadura,et al. World Health Report 2002: Reducing Risks, Promoting Healthy Life , 2004 .
[14] Usdhhs. Health, United States 2003: With Chartbook on Trends in the Health of Americans , 2003 .
[15] Guilbert Jj. The world health report 2002 - reducing risks, promoting healthy life. , 2003 .
[16] E. Rubin,et al. Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.
[17] Yu-Jin Jung,et al. Virulent but not Avirulent Mycobacterium tuberculosis Can Evade the Growth Inhibitory Action of a T Helper 1–dependent, Nitric Oxide Synthase 2–independent Defense in Mice , 2002, The Journal of experimental medicine.
[18] Ira Tabas,et al. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. , 2002, The Journal of clinical investigation.
[19] J. Casanova,et al. Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12‐dependent interferon‐gamma production pathway , 2002, International journal of experimental pathology.
[20] J. Flynn,et al. The Inducible Nitric Oxide Synthase Locus Confers Protection against Aerogenic Challenge of Both Clinical and Laboratory Strains of Mycobacterium tuberculosis in Mice , 2001, Infection and Immunity.
[21] S. Ehlers,et al. Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse. , 2001, Cellular immunology.
[22] R. Zinkernagel,et al. Hypercholesterolemia Exacerbates Virus-Induced Immunopathologic Liver Disease Via Suppression of Antiviral Cytotoxic T Cell Responses1 , 2001, The Journal of Immunology.
[23] R. North,et al. The Relative Importance of T Cell Subsets in Immunity and Immunopathology of Airborne Mycobacterium tuberculosis Infection in Mice , 2001, The Journal of experimental medicine.
[24] I. Orme. Immunology and vaccinology of tuberculosis: can lessons from the mouse be applied to the cow? , 2001, Tuberculosis.
[25] Stalenhoef,et al. Apolipoprotein E‐deficient mice have an impaired immune response to Klebsiella pneumoniae , 2000, European journal of clinical investigation.
[26] S. Kaufmann,et al. Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis. , 2000, The Journal of infectious diseases.
[27] R. Appelberg,et al. Neutrophils Play a Protective Nonphagocytic Role in Systemic Mycobacterium tuberculosis Infection of Mice , 2000, Infection and Immunity.
[28] J. Casanova,et al. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. , 1998, Immunology today.
[29] A. Daugherty,et al. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. , 1998, Journal of lipid research.
[30] G. Hansson,et al. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. , 1998, The Journal of clinical investigation.
[31] W. Heath,et al. Defective TCR expression in transgenic mice constructed using cDNA‐based α‐ and β‐chain genes under the control of heterologous regulatory elements , 1998, Immunology and cell biology.
[32] J. Mudgett,et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[33] N. Maeda,et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[34] Shau-ku Huang,et al. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. , 2005, American journal of respiratory and critical care medicine.
[35] C. Dye,et al. Global tuberculosis control: surveillance planning financing. WHO report 2003. , 2003 .